{"id":48955,"date":"2024-12-02T09:00:11","date_gmt":"2024-12-02T09:00:11","guid":{"rendered":"https:\/\/cardiacinstitute.bg\/?p=48955"},"modified":"2024-12-02T09:52:31","modified_gmt":"2024-12-02T09:52:31","slug":"prof-iana-simova-and-heart-and-brain-team-enrolled-the-first-european-patient-in-an-international-clinical-trial","status":"publish","type":"post","link":"https:\/\/cardiacinstitute.bg\/tr\/2024\/12\/02\/prof-iana-simova-and-heart-and-brain-team-enrolled-the-first-european-patient-in-an-international-clinical-trial\/","title":{"rendered":"Prof. Iana Simova ve &#8216;Kalp ve Beyin&#8217; Pleven ekibi, uluslararas\u0131 bir klinik ara\u015ft\u0131rmaya ilk Avrupal\u0131 hastay\u0131 kaydettirdi"},"content":{"rendered":"<p><i>Deneme, y\u00fcksek riskli kardiyovask\u00fcler hastal\u0131klara y\u00f6nelik yenilik\u00e7i tedavilerin geli\u015ftirilmesinde \u00f6nemli bir ad\u0131m\u0131 i\u015faret ediyor<\/i><\/p>\n<p>Dr. Yana Simova liderli\u011findeki &#8216;Heart and Brain&#8217; Pleven ara\u015ft\u0131rma ekibi, SHASTA-3 klinik \u00e7al\u0131\u015fmas\u0131 i\u00e7in Avrupa&#8217;n\u0131n ilk hastas\u0131n\u0131n ba\u015far\u0131l\u0131 bir \u015fekilde randomize edilmesiyle klinik \u00e7al\u0131\u015fmalarda \u00f6nemli bir kilometre ta\u015f\u0131na ula\u015ft\u0131. \u015eiddetli ailesel hipertrigliseridemi hastalar\u0131n\u0131 hedefleyen \u00e7al\u0131\u015fma, bu y\u00fcksek riskli kardiyovask\u00fcler hastal\u0131k i\u00e7in yenilik\u00e7i tedavilerin geli\u015ftirilmesinde \u00f6nemli bir ad\u0131m\u0131 i\u015faret ediyor.<\/p>\n<p>Ailesel hipertrigliseridemi (AH), tehlikeli derecede y\u00fcksek trigliserit seviyelerine yol a\u00e7an ve kardiyovask\u00fcler olay riskinin artmas\u0131na katk\u0131da bulunan genetik bir bozukluktur. SHASTA-3 \u00e7al\u0131\u015fmas\u0131, trigliserit seviyelerini d\u00fc\u015f\u00fcrmeyi ve ili\u015fkili riskleri en aza indirmeyi ama\u00e7layan yeni bir terap\u00f6tik yakla\u015f\u0131m\u0131n etkinli\u011fini de\u011ferlendirmeyi ama\u00e7lamaktad\u0131r.<\/p>\n<p>Bu ba\u015far\u0131dan dolay\u0131 Arrowhead Pharmaceuticals \u0130cra Kurulu Ba\u015fkan\u0131 John Montgomery, Prof. Simova ve ekibini bizzat tebrik ederek \u00e7al\u0131\u015fmalar\u0131n\u0131n kardiyovask\u00fcler hastal\u0131klar\u0131n anla\u015f\u0131lmas\u0131 ve tedavisinin ilerletilmesindeki \u00f6nemini vurgulad\u0131.<\/p>\n<p>Bu \u00e7al\u0131\u015fma sadece Prof. Simova&#8217;n\u0131n ekibi i\u00e7in \u00f6nemli bir kilometre ta\u015f\u0131n\u0131 de\u011fil, ayn\u0131 zamanda Prof. Simova i\u00e7in \u00f6nemli bir kilometre ta\u015f\u0131 olmas\u0131n\u0131n yan\u0131 s\u0131ra, akademik ara\u015ft\u0131rma ile ila\u00e7 end\u00fcstrisi aras\u0131nda \u00f6nemli bir i\u015fbirli\u011fini de temsil etmektedir. Klinik ila\u00e7 denemelerinin hasta sonu\u00e7lar\u0131n\u0131n iyile\u015ftirilmesinde ve t\u0131p biliminin ilerlemesinde oynad\u0131\u011f\u0131 \u00f6nemli rol\u00fc vurgulamaktad\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Deneme, y\u00fcksek riskli kardiyovask\u00fcler hastal\u0131klara y\u00f6nelik yenilik\u00e7i tedavilerin geli\u015ftirilmesinde \u00f6nemli bir ad\u0131m\u0131 i\u015faret ediyor Dr. Yana Simova liderli\u011findeki &#8216;Heart and Brain&#8217; Pleven ara\u015ft\u0131rma ekibi, SHASTA-3 klinik \u00e7al\u0131\u015fmas\u0131 i\u00e7in Avrupa&#8217;n\u0131n ilk hastas\u0131n\u0131n ba\u015far\u0131l\u0131 bir \u015fekilde randomize edilmesiyle klinik \u00e7al\u0131\u015fmalarda \u00f6nemli bir kilometre ta\u015f\u0131na ula\u015ft\u0131. \u015eiddetli ailesel hipertrigliseridemi hastalar\u0131n\u0131 hedefleyen \u00e7al\u0131\u015fma, bu y\u00fcksek riskli kardiyovask\u00fcler hastal\u0131k i\u00e7in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[200],"tags":[],"class_list":["post-48955","post","type-post","status-publish","format-standard","hentry","category-haber"],"_links":{"self":[{"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/posts\/48955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/comments?post=48955"}],"version-history":[{"count":2,"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/posts\/48955\/revisions"}],"predecessor-version":[{"id":48957,"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/posts\/48955\/revisions\/48957"}],"wp:attachment":[{"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/media?parent=48955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/categories?post=48955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cardiacinstitute.bg\/tr\/wp-json\/wp\/v2\/tags?post=48955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}